Charterhouse begins groundwork for $700 mln-plus Doc Generici sale: Reuters

European buyout firm Charterhouse is preparing for the sale of its Italian generic drugs business Doc Generici and has contacted investment banks to select an adviser, two sources familiar with the matter said.

DealsNorth AmericaUSBriefs